Detalhe da pesquisa
1.
Myeloid molecular characteristics of human γδ T cells support their acquisition of tumor antigen-presenting capacity.
Cancer Immunol Immunother
; 64(8): 941-9, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25904200
2.
Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanism via recruitment of myeloid-derived suppressor cells.
Int J Cancer
; 134(8): 1810-22, 2014 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24150772
3.
Dendritic cell vaccine with mRNA targeted to the proteasome by polyubiquitination.
Biochem Biophys Res Commun
; 371(2): 242-6, 2008 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-18423376
4.
A phase I/IIa clinical trial of immunotherapy for elderly patients with acute myeloid leukaemia using dendritic cells co-pulsed with WT1 peptide and zoledronate.
Br J Haematol
; 153(6): 796-9, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21477159
5.
Cytotoxic T lymphocytes block tumor growth both by lytic activity and IFNγ-dependent cell-cycle arrest.
Cancer Immunol Res
; 3(1): 26-36, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25127875
6.
Augmented anti-metastatic efficacy of a selective matrix metalloproteinase inhibitor, MMI-166, in combination with CPT-11.
Clin Exp Metastasis
; 19(6): 519-26, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12405289
7.
Disruption of dystroglycan axis by beta-dystroglycan processing in cardiomyopathic hamster muscle.
Neuromuscul Disord
; 13(10): 796-803, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14678802
8.
Selective matrix metalloproteinase inhibitor, N-biphenyl sulfonyl phenylalanine hydroxamic acid, inhibits the migration of CD4+ T lymphocytes in patients with HTLV-I-associated myelopathy.
J Neuroimmunol
; 127(1-2): 134-8, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12044984
9.
Preclinical combination chemotherapy of nedaplatin with gemcitabine against gemcitabine-refractory human lung cancer.
Cancer Lett
; 182(1): 61-8, 2002 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-12175524
10.
Reduction of in vivo tumor growth by MMI-166, a selective matrix metalloproteinase inhibitor, through inhibition of tumor angiogenesis in squamous cell carcinoma cell lines of head and neck.
Cancer Lett
; 178(2): 151-9, 2002 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-11867199
11.
A significant enhancement of therapeutic effect against hepatic metastases of M5076 in mice by a liposomal interleukin-2 (mixture).
J Control Release
; 82(2-3): 183-7, 2002 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-12175736
12.
Augmented growth inhibition of B16-BL6 melanoma by combined treatment with a selective matrix metalloproteinase inhibitor, MMI-166, and cytotoxic agents.
Anticancer Res
; 22(6A): 3253-9, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12530072
13.
[Combination chemotherapy of paclitaxel followed by nedaplatin for human ovarian cancer].
Gan To Kagaku Ryoho
; 29(11): 1943-9, 2002 Nov.
Artigo
em Japonês
| MEDLINE | ID: mdl-12465394
14.
Large-scale expansion of γδ T cells and peptide-specific cytotoxic T cells using zoledronate for adoptive immunotherapy.
Int J Oncol
; 45(5): 1847-56, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25189159
15.
Impaired and imbalanced cellular immunological status assessed in advanced cancer patients and restoration of the T cell immune status by adoptive T-cell immunotherapy.
Int Immunopharmacol
; 18(1): 90-7, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24269583
16.
Prospective evaluation of safety of immune-cell therapy for patients with various types of advanced cancer.
Anticancer Res
; 34(8): 4601-7, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25075106
17.
Combination therapy with dendritic cell vaccine and IL-2 encapsulating polymeric micelles enhances intra-tumoral accumulation of antigen-specific CTLs.
Int Immunopharmacol
; 23(2): 499-504, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25284343
18.
Zoledronate-pulsed dendritic cell-based anticancer vaccines.
Oncoimmunology
; 2(9): e25636, 2013 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24319636
19.
Clinical scale electroloading of mature dendritic cells with melanoma whole tumor cell lysate is superior to conventional lysate co-incubation in triggering robust in vitro expansion of functional antigen-specific CTL.
Int Immunopharmacol
; 15(3): 488-97, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23474736
20.
Immunotherapy of autologous tumor lysate-loaded dendritic cell vaccines by a closed-flow electroporation system for solid tumors.
Anticancer Res
; 33(7): 2971-6, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23780988